Flatiron ResearchX On-Demand Webinar on RWE in Regulatory Submissions

Flatiron ResearchX invited real world evidence (RWE) and pharma leaders to discuss how RWE impacts submissions to regulatory bodies. Available on-demand, the webinar covers RWE applications throughout the research and development pipeline.

“This ResearchX session included presentations from Eli Lilly and Bristol Myers Squibb about how their organizations have successfully applied RWE in recent regulatory submissions, as well as a presentation on Flatiron’s evolving perspective on the use of RWE for regulatory use.” Watch the webinar here.

(Source: Flatiron, 2021)